Your browser doesn't support javascript.
loading
Incidence of and indications for sperm donor restriction - analysis of patients continuing treatment: a retrospective single-centre study.
Vanbelleghem, Eva; Muyshond, Vanessa; Colman, Roos; Vanden Meerschaut, Frauke; Stoop, Dominic; Janssens, Sandra; Tilleman, Kelly.
Afiliación
  • Vanbelleghem E; Department for Medical Genetics, Ghent University Hospital, Belgium.
  • Muyshond V; Department for Reproductive Medicine, Ghent University Hospital, Belgium.
  • Colman R; Biostatistics Unit, Department of Public Health and Primary Care, Ghent University, Belgium.
  • Vanden Meerschaut F; Department for Reproductive Medicine, Ghent University Hospital, Belgium.
  • Stoop D; Department for Reproductive Medicine, Ghent University Hospital, Belgium.
  • Janssens S; Department for Medical Genetics, Ghent University Hospital, Belgium.
  • Tilleman K; Department for Reproductive Medicine, Ghent University Hospital, Belgium.. Electronic address: Kelly.Tilleman@UZGent.Be.
Reprod Biomed Online ; 47(2): 103224, 2023 08.
Article en En | MEDLINE | ID: mdl-37244865
ABSTRACT
RESEARCH QUESTION What are the incidence of and indications for sperm donor restriction due to suspected/confirmed disease risk, and the future treatment choices of patients using these sperm donors?

DESIGN:

This single-centre retrospective study involved donors who had restrictions on the use of their imported spermatozoa from January 2010 to December 2019, and current or previous recipients. Indications for sperm restriction and the characteristics of patients undergoing medically assisted reproduction (MAR) treatment with these specimens at the time of restriction were collected. Differential characteristics of women who decided on whether or not to contintue the procedure were assessed. Characteristics potentially leading to treatment continuation were identified.

RESULTS:

Of 1124 sperm donors identified, 200 (17.8%) were restricted, most commonly for multifactorial (27.5%) and autosomal recessive (17.5%) disorders. The spermatozoa had been used for 798 recipients, of whom 172, receiving spermatozoa from 100 donors, were informed about the restriction and constituted the 'decision cohort'. The specimens from the restricted donors were accepted by 71 (approximately 40%) patients, with 45 (approximately 63%) eventually using the restricted donor for their future MAR treatment. The odds of accepting the restricted spermatozoa decreased with increasing age (OR 0.857, 95% CI 0.800-0.918, P < 0.001) and the time between MAR treatment and the restriction date (OR 0.806, 95% CI 0.713-0.911, P < 0.001).

CONCLUSION:

Donor restriction due to suspected/confirmed disease risk is relatively frequent. This affected a relevant number of women (around 800), of whom 172 (approximately 20%) had to decide whether or not to use these donors further. Although donor screening is being performed thoroughly, there remain health risks for donor children. Realistic counselling of all stakeholders involved is necessary.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Semen / Donantes de Tejidos Tipo de estudio: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Female / Humans / Male Idioma: En Revista: Reprod Biomed Online Asunto de la revista: MEDICINA REPRODUTIVA Año: 2023 Tipo del documento: Article País de afiliación: Bélgica

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Semen / Donantes de Tejidos Tipo de estudio: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Female / Humans / Male Idioma: En Revista: Reprod Biomed Online Asunto de la revista: MEDICINA REPRODUTIVA Año: 2023 Tipo del documento: Article País de afiliación: Bélgica